Recruiting

Drug Eluting Stents

Sponsor:

Providence Health & Services

Code:

NCT00487604

Conditions

Coronary Artery Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The purpose of this study is to determine whether the use of drug eluting stents is associated with higher rates of death, myocardial infarction, and major bleeding. In addition, the overall economic costs of implanting drug eluting stents compared to bare metal stents will be assessed.

Conditions

Coronary Artery Disease

Study ID

NCT00487604

Start date

May, 2007

Status verified date

Apr, 2007

Completion date

May, 2008

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Coronary artery stenting between March 1, 2001 and March 30, 2006

Exclusion Criteria:

  • Implanted investigational drug eluting stents

Study Design

Enrollment

9800 participants

Anticipated

Interventions and Outcome Measures

Central Contacts and Locations

Central contacts

Lynn A. Shuler, RN, MA

509.474.4302lshuler@this.org

Sandra J. Albritton, RN, MSN

509.474.4345salbritt@this.org

Locations

Sacred Heart Medical Center

Recruiting

Spokane, Washington, United States, 99204

Contacts

Sandra J. Albritton, RN, MN

509-474-4345salbritt@this.org

Lynn A. Shuler, RN, MA

509.474.4302lshuler@this.org

More Information

Sponsor

Providence Health & Services

Last update posted

Aug 2, 2007

Last verified

Apr, 2007

Keywords

  • Coronary Artery Disease
  • Drug Eluting Stent
  • Bare Metal Stent
  • Subacute thrombosis
  • Bleeding
  • Economic

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Providence Health & Services on 2007-08-02.